IONS Similar Chart Price Prediction
The price of IONS is predicted to go up -10.37%, based on the high correlation periods with IRTC. The similarity of these two price pattern on the periods is 93.11%.
IONS
IRTC
Down: -10.37%Similarity: 93.11%
IONS Revenue Forecast
IONS EPS Forecast
IONS FAQs
What is bull’s view on IONS?
What is bear's view on IONS?
What is IONS revenue forecast for next quarter？
What is IONS eps forecast for next quarter？
IONS VS S&P500
Ionis' antisense technology and intellectual property estate have allowed the firm to create an entirely new class of therapeutics for difficult-to-treat diseases.
Antisense therapeutics have the potential to gain access to well-studied targets in the cell that are currently deemed
IONS Analyst's Forecast
Debjit Chattopadhyay
Guggenheim
Strong Buy
2024-10-09
Price Target
$70 → $65
Upside
+70.78%
Guggenheim analyst Debjit Chattopadhyay lowered the firm's price target on Ionis Pharmaceuticals to $65 from $70 and keeps a Buy rating on the shares. The firm updated its model ahead of the Q3 report, lowering collaboration revenue estimates, modestly increasing SG&A to account for commercial activity ramp and updating the float following the secondary offering.
